HIV TREATMENT
2020
Action 27. Mobilize their networks and work with communities to help build treatment literacy, generate demand, and expand access to ARVs among children.
Action 34. Increase efforts to share information on the roll-out of new paediatric formulations, including lessons learned.
Paediatric HIV & TB : Rome Action Plan
Penta commits to:
​
225. Setting up a data collection system in collaboration with the Ministry of Health of Uganda to monitor the safety and effectiveness of dolutegravir in the paediatric population.
​
226. Study the PK, safety and virological/immunological impact of monoclonal anti-HIV antibodies in combination with antivirals in children responding to therapy, by 2025.
​
227. Promoting the use of real-world data in combination with clinical trial data for regulatory
purposes.
-
​
​